Leonteq Securities AG’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.61M Sell
21,354
-5,100
-19% -$976K 0.16% 101
2026
Q1
$4.85M Sell
26,454
-1,506
-5% -$277K 0.18% 96
2025
Q4
$4.92M Buy
27,960
+4,843
+21% +$791K 0.15% 115
2025
Q3
$3.24M Sell
23,117
-85,751
-79% -$11.6M 0.1% 146
2025
Q2
$13.7M Buy
108,868
+27,209
+33% +$3.39M 0.53% 38
2025
Q1
$11.1M Sell
81,659
-32,704
-29% -$4.68M 0.62% 24
2024
Q4
$17.5M Buy
114,363
+101,892
+817% +$17.2M 1.18% 12
2024
Q3
$2.42M Buy
+12,471
New +$2.61M 0.18% 119
2024
Q2
Sell
-22,724
Closed -$4.94M 1206
2024
Q1
$4.9M Buy
22,724
+14,760
+185% +$3.46M 0.37% 69
2023
Q4
$2.06M Buy
7,964
+1,479
+23% +$363K 0.12% 161
2023
Q3
$1.67M Buy
6,485
+1,551
+31% +$415K 0.09% 211
2023
Q2
$1.41M Buy
4,934
+4,661
+1,707% +$1.39M 0.07% 234
2023
Q1
$75.9K Sell
273
-10,402
-97% -$2.88M ﹤0.01% 692
2022
Q4
$2.96M Sell
10,675
-5,806
-35% -$1.64M 0.11% 144
2022
Q3
$4.4M Sell
16,481
-95,302
-85% -$20.2M 0.17% 112
2022
Q2
$22.8M Sell
111,783
-11,419
-9% -$2.33M 0.86% 26
2022
Q1
$25.9M Buy
123,202
+37,082
+43% +$8.06M 0.93% 21
2021
Q4
$20.7M Buy
86,120
+50,704
+143% +$13M 0.74% 27
2021
Q3
$10M Buy
35,416
+34,169
+2,740% +$11.2M 0.43% 61
2021
Q2
$432K Buy
+1,247
New +$378K 0.03% 415

Other funds holding BIIB

Leonteq Securities AG's BIIB Position: Q2 2026 in Review

Leonteq Securities AG reduced its Biogen (BIIB) stake by 19% in Q2 2026, selling an estimated $976K and leaving 21,354 shares worth $4.61M. The position accounts for 0.16% of the portfolio, ranked #101.

Leonteq Securities AG first reported a position in BIIB in Q2 2021 and has held it in 20 quarters since. The position peaked at $25.9M in Q1 2022. 1,034 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Leonteq Securities AG held 21,354 shares of Biogen worth $4.61M as of Q2 2026.
  • Leonteq Securities AG sold 5,100 Biogen shares in Q2 2026, an estimated $976K.
  • Biogen made up 0.16% of Leonteq Securities AG's portfolio in Q2 2026, its #101 holding.
  • Leonteq Securities AG first reported a position in Biogen in Q2 2021 and has held it in 20 quarters since.
  • Leonteq Securities AG's Biogen position peaked at $25.9M in Q1 2022.
  • 1,034 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.